By Daniel Wilson ( May 23, 2013, 3:57 PM EDT) -- Daiichi Sankyo Co. Ltd. is weighing litigation against certain former shareholders of its majority-owned Ranbaxy Laboratories Ltd., saying Wednesday that it believed the shareholders had covered up critical information over tainted drug investigations leading to a recent $500 million U.S. civil and criminal settlement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.